San Diego, California, United States In 1998 was created Optimer Pharmaceuticals, which is appeared as Corporate Investor. The venture was found in North America in United States. The main office of represented Corporate Investor is situated in the San Diego.
The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2012. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2007.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Optimer Pharmaceuticals, startups are often financed by Intersouth Partners, I. Wistar Morris III, Aisling Capital. The meaningful sponsors for the fund in investment in the same round are Intersouth Partners, I. Wistar Morris III, Aisling Capital. In the next rounds fund is usually obtained by Quaker BioVentures, Ontario Teachers' Pension Plan, Intersouth Partners.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 1 and less years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Health Care. Among the most popular portfolio startups of the fund, we may highlight Cempra.
Related Funds
| Fund Name | Location |
| Advent Capital Management, LLC | England, London, United Kingdom |
| Area Science Park | - |
| BIA Digital Partners | - |
| Grammarly | California, San Francisco, United States |
| Longview Partners | Longview, Texas, United States |
| Partners Healthcare Group | Brentwood, Tennessee, United States |
| Shanghai Liying Ziben | China, Shanghai |
| Trend Capital | Baoshan, China, Shanghai |
| Tuas Capital Partners | Central, Central Region, Singapore |
| Venture Hacks | California, San Francisco, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Cempra | $10M | 01 Jul 2007 | North Carolina, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Cempra | $10M | 01 Jul 2007 | North Carolina, United States |
